Pulse Biosciences reports 100% 6-month and 96% 12-month ablation success in nPulse study

PULSE BIOSCIENCES, INC.

Sustained 100% procedural success at 6 months (95/95 evaluable patients by holter).
Sustained 96% procedural success at 12 months (51/53 evaluable patients).
90% Kaplan-Meier freedom from AF/AFL/AT at one year; low SAE rate of 1.7% (3/177).
Efficient procedure: left atrial dwell 18.6 min, total procedure 60.2 min, fluoroscopy 9.4 min.
Data presented at Heart Rhythm 2026 by Dr. Vivek Reddy; 177 patients treated across 7 European sites.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.